OSLO, Norway, April 12, 2023 /PRNewswire/ -- Photocure ASA
(OSE: PHO), calls for the annual general meeting of Photocure ASA
to be held on 3 May 2023 at 17:00
hours (CEST), virtual through the general meeting portal
administered by Euronext Securities Oslo (the "Euronext Securities
Portal").
The general meeting will be webcasted live and a link will be
available on the company's website in due time in advance of the
general meeting. It will not be possible to attend in person.
Shareholders may also vote in advance or submit a proxy with voting
instructions.
The notice convening the general meeting, including the agenda
and the board's proposals to the matters to be dealt with, is
enclosed with this notification and will be sent to all
shareholders with known addresses.
Relevant documents referred to in the notice are made available
on www.photocure.com.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative
solutions to improve the lives of bladder cancer patients. Our
unique technology, which makes cancer cells glow bright pink, has
led to better health outcomes for patients worldwide. Photocure is
headquartered in Oslo, Norway, and
listed on the Oslo Stock Exchange (OSE: PHO). For more information,
please visit us at www.photocure.com, www.hexvix.com or
www.cysview.com
This information is subject to the disclosure requirements
pursuant to section 5-12 of the Norwegian Securities Trading
Act.
The following files are available for download:
https://mb.cision.com/Main/17498/3749685/1979962.pdf
|
Release
|
https://mb.cision.com/Public/17498/3749685/ab4c38b67c2b1f70.pdf
|
Notice of ordinary
general meeting 2023 (English)
|
https://mb.cision.com/Public/17498/3749685/929534392275e8ae.pdf
|
Notice of ordinary
general meeting 2023 (Norwegian)
|
View original
content:https://www.prnewswire.co.uk/news-releases/photocure-asa--notice-of-the-annual-general-meeting-3-may-2023-301795685.html